HV

Herman Verrelst

Description

Herman Verrelst

Investor Profile

Herman Verrelst has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Hospital, Medical.

Stage Focus

  • Series A (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Hospital
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Herman Verrelst frequently co-invest with?

Gemma Frisius Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Limburgse Reconversie Maatschappij
Europe, Limburg, Belgium, Hasselt
Co-Investments: 1
imec
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1

Which angels does Herman Verrelst often collaborate with?

AV
Europe, Antwerpen, Belgium, Antwerp
Shared Deals: 1

What are some of recent deals done by Herman Verrelst?

UgenTec

Hasselt, Limburg, Belgium

UgenTec delivers an independent diagnostic platform to help molecular labs with their DNA (PCR) analyses.

BiotechnologyHospitalMedical
Series AMar 29, 2018
Amount Raised: $9,226,817